Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 269

Similar articles for PubMed (Select 17976100)

1.

Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.

Lellouche N, De Diego C, Vaseghi M, Buch E, Cesario DA, Mahajan A, Wiener I, Fonarow GC, Boyle NG, Shivkumar K.

Pacing Clin Electrophysiol. 2007 Nov;30(11):1363-8.

PMID:
17976100
2.

Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.

Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G; Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group.

Am Heart J. 2008 Sep;156(3):520-6. doi: 10.1016/j.ahj.2008.04.013. Epub 2008 Jul 7.

PMID:
18760135
3.

Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy.

Fung JW, Yip GW, Zhang Q, Fang F, Chan JY, Li CM, Wu LW, Chan GC, Chan HC, Yu CM.

Heart Rhythm. 2008 Jun;5(6):780-6. doi: 10.1016/j.hrthm.2008.02.043. Epub 2008 Mar 7.

PMID:
18467188
4.

Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.

Ferreira AM, Adragão P, Cavaco DM, Candeias R, Morgado FB, Santos KR, Santos E, Silva JA.

Europace. 2008 Jul;10(7):809-15. doi: 10.1093/europace/eun135. Epub 2008 May 28.

5.

The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.

Ng K, Kedia N, Martin D, Tchou P, Natale A, Wilkoff B, Starling R, Grimm RA.

Pacing Clin Electrophysiol. 2007 Feb;30(2):193-8.

PMID:
17338715
6.

Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm.

Hauck M, Bauer A, Voss F, Katus HA, Becker R.

Clin Res Cardiol. 2009 Mar;98(3):189-94. doi: 10.1007/s00392-008-0740-z. Epub 2008 Nov 25.

PMID:
19034378
7.

Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation.

Molhoek SG, Bax JJ, Bleeker GB, Boersma E, van Erven L, Steendijk P, van der Wall EE, Schalij MJ.

Am J Cardiol. 2004 Dec 15;94(12):1506-9.

PMID:
15589005
8.

Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.

Kiès P, Leclercq C, Bleeker GB, Crocq C, Molhoek SG, Poulain C, van Erven L, Bootsma M, Zeppenfeld K, van der Wall EE, Daubert JC, Schalij MJ, Bax JJ.

Heart. 2006 Apr;92(4):490-4. Epub 2005 Sep 13.

9.

Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.

de Sisti A, Toussaint JF, Lavergne T, Ollitrault J, Abergel E, Paziaud O, Ait Said M, Sader R, LE Heuzey JY, Guize L.

Pacing Clin Electrophysiol. 2005 Dec;28(12):1260-70.

PMID:
16403157
10.

Left ventricular apical wall motion abnormality is associated with lack of response to cardiac resynchronization therapy in patients with ischemic cardiomyopathy.

Buch E, Lellouche N, De Diego C, Vaseghi M, Cesario DA, Fujimura O, Wiener I, Child JS, Boyle NG, Shivkumar K.

Heart Rhythm. 2007 Oct;4(10):1300-5. Epub 2007 Jul 14.

PMID:
17905335
11.

The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy.

Kamath GS, Cotiga D, Koneru JN, Arshad A, Pierce W, Aziz EF, Mandava A, Mittal S, Steinberg JS.

J Am Coll Cardiol. 2009 Mar 24;53(12):1050-5. doi: 10.1016/j.jacc.2008.12.022.

12.

Burden of atrial fibrillation after cardiac resynchronization therapy.

Adelstein EC, Saba S.

Am J Cardiol. 2007 Jul 15;100(2):268-72. Epub 2007 Jun 6.

PMID:
17631081
13.

Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.

Saxon LA, Greenfield RA, Crandall BG, Nydegger CC, Orlov M, VAN Genderen R.

J Cardiovasc Electrophysiol. 2006 May;17(5):520-5.

PMID:
16684026
14.

Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.

Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP, van Hemel NM.

Am J Cardiol. 2007 May 1;99(9):1252-7. Epub 2007 Mar 13.

PMID:
17478153
15.
16.

Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.

Lellouche N, De Diego C, Cesario DA, Vaseghi M, Horowitz BN, Mahajan A, Wiener I, Boyle NG, Fonarow GC, Shivkumar K.

Am J Cardiol. 2007 Jan 15;99(2):242-6. Epub 2006 Nov 20.

PMID:
17223426
17.

QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure.

Molhoek SG, VAN Erven L, Bootsma M, Steendijk P, Van Der Wall EE, Schalij MJ.

Pacing Clin Electrophysiol. 2004 Mar;27(3):308-13.

PMID:
15009855
18.

Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.

Borleffs CJ, Ypenburg C, van Bommel RJ, Delgado V, van Erven L, Schalij MJ, Bax JJ.

Heart Rhythm. 2009 Mar;6(3):305-10. doi: 10.1016/j.hrthm.2008.12.017. Epub 2008 Dec 13.

PMID:
19251202
19.
20.

Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics.

Leclercq C, Padeletti L, Cihák R, Ritter P, Milasinovic G, Gras D, Paul V, Van Gelder IC, Stellbrink C, Rieger G, Corbucci G, Albers B, Daubert JC; CHAMP Study Investigators.

Europace. 2010 Jan;12(1):71-7. doi: 10.1093/europace/eup318. Epub .

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk